# 2-Week Study In People With Nonalcoholic Fatty Liver Disease

> **NCT03513588** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 48 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis
- Non-alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** PF-06865571
- **DRUG:** PF-06865571

## Key facts

- **NCT ID:** NCT03513588
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-21
- **Primary completion:** 2019-03-08
- **Final completion:** 2019-04-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513588, "2-Week Study In People With Nonalcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03513588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*